Simon Plyte

Critic
DISC Type : C

Chief Scientific Officer at BIOMUNEX PHARMACEUTICALS

Paris, Île-de-France, France

Overview

Simon Plyte is the Chief Scientific Officer at Biomunex Pharmaceuticals, bringing over 20 years of leadership experience in the biotechnology industry. His expertise is in immuno-oncology and the discovery of innovative drugs, particularly bispecific antibodies. He holds a PhD in biochemistry and biophysics from the University of Portsmouth.

He is pioneering the development of MAIT engagers, a novel class of bispecific antibodies intended to provide a safer and more effective cancer therapy.

Personality Overview

Negotiator

Precise

Objective Thinker

They like to do things independently and don’t look for support from others.  They are quite likely to negotiate on pricing or other key terms. They don’t appreciate bells and whistles unless backed by data.

Topics They Care About

MAIT Engagers
He frequently presents his company's innovative MAIT engager platform at scientific conferences, positioning it as a safer alternative to traditional T-cell engagers for cancer therapy.
Immuno-Oncology
His recent career, including senior roles at Merus and Molecular Partners, has been dedicated to advancing immuno-oncology therapeutics and building pipelines to treat various cancers.
Bispecific Antibodies
He has extensive experience developing bi- and multi-specific antibody platforms, including his current work with Biomunex's proprietary BiXAb® technology.

Media Appearances

Simon has no verified media appearances

Work History

10-2021
Chief Scientific Officer at BIOMUNEX PHARMACEUTICALS
10-2018 - 9-2021
Vice President Immune Oncology at Merus
1-2018 - 9-2018
Senior Director, Immune Oncology at Molecular Partners AG
4-2015 - 12-2017
Director, Immune Modulation II at Boehringer Ingelheim
10-2013 - 4-2015
Director, New Biological Entities II at Boehringer Ingelheim

Education

1986 - 1990
PhD from University of Portsmouth
1982 - 1986
BsC from University of Greenwich

More Information

Social Presence :

Prographics :

Exp : 19 Location : Paris, Île-de-France, France Job Level : Leadership Designation : Chief Scientific Officer at BIOMUNEX PHARMACEUTICALS
URL has been copied!

Insights For Selling To Simon

During A Call Or A Meeting

DO's

  • Leverage facts and figures wherever possible; use percentages, numbers etc.
  • Be ready for penetrating questions and critical examination of your pitch
  • Tell them what ROI they can expect

DONT's

  • Make extra effort to not seem pushy or confrontational
  • Don’t rush them till they have clearly gotten all the necessary information
  • Avoid pushing them too much to involve other stakeholders unless it is critical

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Simon is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from Simon

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will Simon move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Simon take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Simon

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.